Letter: infliximab therapy for patients with inflammatory bowel disease – some unanswered questions
Publisher： John Wiley & Sons Inc
E-ISSN： 1365-2036|269-2813|9|1133-1133
ISSN： 0269-2813
Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.269-2813, Iss.9, 2015-11, pp. : 1133-1133
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
